Russia to Build Painkiller Raw Material Plant by 2030
Russia plans to complete a facility for producing active pharmaceutical substances for painkillers by 2030, ensuring domestic supply of raw materials for pain medication production.
Consensus
- Russia aims to ensure domestic production of raw materials for painkillers.
- A new facility for producing active pharmaceutical substances for analgesics is planned to be operational by 2030.
- Tatyana Golikova, Deputy Prime Minister, announced this at a national scientific-practical conference.
- The initiative is part of the 'Pharma-2030' strategy to reduce reliance on imported pharmaceutical raw materials.
- Russia already produces 86% of essential and critical medicines on its national list.
Points of divergence
- In 2025, drug and medical material output increased by 14.2%. — vedomosti
- Ministry of Economic Development raised the 2026 drug production growth forecast to 6%. — vedomosti
- By 2030, over 500 new pharmaceuticals are expected to be introduced to the Russian market. — vedomosti
- As of July 2024, 46% of drug names in Russia were produced via full cycle, with domestic production at 63%. — vedomosti
- Russia plans to expand its national vaccination calendar in 2027 to include vaccines for meningococcus, HPV, rotavirus, and chickenpox. — vesti
Coverage (2 sources)
- In Russia, a factory for painkiller precursors will be built by 2030 — Ведомости
- Golikova: production of painkillers in Russia is ensured by domestic raw materials — Вести